Grunenthal GmbH:企業の戦略的SWOT分析

◆英語タイトル:Grunenthal GmbH - Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1779
◆発行会社(調査会社):GlobalData
◆発行日:2019年11月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Grunenthal GmbH – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Grunenthal GmbH (Grunenthal) is a research-oriented pharmaceutical company. It researches, develops and markets products for the treatment of pain and innovative formulations of established active substances. The company provides new chemical entities including opioids for moderate to severe pain, vanilloid receptors and KCNQ channel openers for chronic neuropathic pain; and the Bradykinin receptor for the treatment of chronic diseases with inflammation. Grunenthal also focuses on discovering new methods to treat pain, developing new medical devices, and new platform technologies for drug delivery. The company operates along with subsidiaries in Europe, Latin America and the US. Grunenthal is headquartered in Aachen, Germany.

Grunenthal GmbH Key Recent Developments

May 02,2019: Five young scientists win EFIC-Grunenthal grant 2018
Jan 22,2019: Grunenthal appoints Fabian Raschke as Chief Financial Officer (CFO)
Dec 07,2018: Research project aims to make pain “visible”
Oct 31,2018: AstraZeneca signs $922m licensing deal with Grünenthal
Jun 15,2018: Grunenthal Selected as One of the Best Employers in Europe for the Third Time

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Grunenthal GmbH – Key Facts
Grunenthal GmbH – Key Employees
Grunenthal GmbH – Key Employee Biographies
Grunenthal GmbH – Major Products and Services
Grunenthal GmbH – History
Grunenthal GmbH – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Grunenthal GmbH – Business Description
R&D Overview
Grunenthal GmbH – Corporate Strategy
Grunenthal GmbH – SWOT Analysis
SWOT Analysis – Overview
Grunenthal GmbH – Strengths
Grunenthal GmbH – Weaknesses
Grunenthal GmbH – Opportunities
Grunenthal GmbH – Threats
Grunenthal GmbH – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Grunenthal GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Grunenthal GmbH, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Grunenthal GmbH, Recent Deals Summary
Section 4 – Company’s Recent Developments
May 02, 2019: Five young scientists win EFIC-Grunenthal grant 2018
Jan 22, 2019: Grunenthal appoints Fabian Raschke as Chief Financial Officer (CFO)
Dec 07, 2018: Research project aims to make pain “visible”
Oct 31, 2018: AstraZeneca signs $922m licensing deal with Grünenthal
Jun 15, 2018: Grunenthal Selected as One of the Best Employers in Europe for the Third Time
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Grunenthal GmbH, Key Facts
Grunenthal GmbH, Key Employees
Grunenthal GmbH, Key Employee Biographies
Grunenthal GmbH, Major Products and Services
Grunenthal GmbH, History
Grunenthal GmbH, Other Locations
Grunenthal GmbH, Subsidiaries
Grunenthal GmbH, Key Competitors
Grunenthal GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Grunenthal GmbH, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Grunenthal GmbH, Recent Deals Summary

List of Figures
Grunenthal GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Grunenthal GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Grunenthal GmbH:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Golden State Foods:企業の戦略・SWOT・財務情報
    Golden State Foods - Strategy, SWOT and Corporate Finance Report Summary Golden State Foods - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Gulf Resources Inc (GURE):企業の財務・戦略的SWOT分析
    Gulf Resources Inc (GURE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Blueprint Medicines Corp (BPMC)-医療機器分野:企業M&A・提携分析
    Summary Blueprint Medicines Corp (Blueprint) is a biotechnology company that develops drugs for the treatment of cancers. The company discovers selective kinase inhibitors for genomically defined cancer subsets. Its pipeline products include BLU-285, for treatment resistant gastrointestinal stromal …
  • Denison Mines Corp (DNN):企業の財務・戦略的SWOT分析
    Denison Mines Corp (DNN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Allergy Therapeutics Plc (AGY):企業の財務・戦略的SWOT分析
    Allergy Therapeutics Plc (AGY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Mitsubishi Chemical Holdings Corporation:戦略・SWOT・企業財務分析
    Mitsubishi Chemical Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Chemical Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Parkland Fuel Corp (PKI):企業の財務・戦略的SWOT分析
    Parkland Fuel Corp (PKI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Intellia Therapeutics Inc (NTLA):企業の財務・戦略的SWOT分析
    Summary Intellia Therapeutics Inc (Intellia Therapeutics) is a genome editing company that develops proprietary curative therapeutics using CRISPR/Cas9 technology. The company develops in vivo programs for the treatment of liver diseases such as alpha-1 antitrypsin deficiency, hepatitis B infection, …
  • Odebrecht S.A.:企業の戦略・SWOT・財務情報
    Odebrecht S.A. - Strategy, SWOT and Corporate Finance Report Summary Odebrecht S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Aradigm Corp (ARDM):企業の財務・戦略的SWOT分析
    Aradigm Corp (ARDM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Bosch Packaging Technology GmbH:企業の戦略・SWOT・財務情報
    Bosch Packaging Technology GmbH - Strategy, SWOT and Corporate Finance Report Summary Bosch Packaging Technology GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Triumph Group Inc:企業のM&A・事業提携・投資動向
    Triumph Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Triumph Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Arqvia Group Ltd:企業の戦略・SWOT・財務分析
    Arqvia Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Arqvia Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Cerus Corp (CERS)-医療機器分野:企業M&A・提携分析
    Summary Cerus Corp (Cerus) is a biomedical products company that focuses in the field of blood transfusion safety. It develops and commercializes the INTERCEPT Blood System to enhance blood safety. INTERCEPT Blood System reduces the risk of transfusion-transmitted infections by inactivating a wide r …
  • Petsec Energy Ltd (PSA):石油・ガス:M&Aディール及び事業提携情報
    Summary Petsec Energy Ltd (Petsec Energy) is an oil and gas company that offers oil and gas exploration, development, and production. The Company holds interests in two oil and gas production fields located onshore Louisiana, the US in Mystic Bayou and Jeanerette Fields. It provides leases, explorat …
  • Optiscan Imaging Limited (OIL)-医療機器分野:企業M&A・提携分析
    Summary Optiscan Imaging Limited (Optiscan) is a technology and product development company. It focuses on the development and application of microscopic imaging technologies for medical procedures. The company’s key product is ViewnVivo, a miniaturized fluorescence endo-microscope platform that bri …
  • AliveCor Inc:医療機器:M&Aディール及び事業提携情報
    Summary AliveCor Inc (AliveCor) is a heart rate measuring technology provider. The company offers kardia mobile and kardia application. It provides medical-grade EKG in just thirty seconds. AliveCor’s kardia offers easy to use, affordable, portable and trusted. The company track data over time and m …
  • Doosan Corp:企業の戦略・SWOT・財務分析
    Doosan Corp - Strategy, SWOT and Corporate Finance Report Summary Doosan Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Land Securities Group PLC:企業の戦略・SWOT・財務情報
    Land Securities Group PLC - Strategy, SWOT and Corporate Finance Report Summary Land Securities Group PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • University of Dundee-製薬・医療分野:企業M&A・提携分析
    Summary University of Dundee (Dundee) is an educational research university that offers a range of undergraduate, postgraduate, postgraduate research degree, distant learning and English language programs. The university offers a wide range of academic and research courses in various disciplines suc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆